Jennison Associates’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$85.2M Buy
2025
Q2
$57.1M Sell
2025
Q1
$71.1M Sell
2024
Q4
$138M Sell
2024
Q3
$143M Buy
2024
Q2
$125M Sell
2024
Q1
$132M Buy
2023
Q4
$90.6M Buy
2023
Q3
$42.6M Buy
2023
Q2
$8.32M Buy